Weight loss drug Wegovy can lower heart attack, stroke risk by 20%

Popular weight loss drug Wegovy can lower the risk of major cardiovascular events such as heart attack, stroke by 20 per cent, according to the results of a major trial announced on Tuesday.Novo Nordisk's semaglutide (sold as Wegovy) is a ...

Related Keywords

London ,City Of ,United Kingdom ,Martin Holst Lange ,Development At Novo Nordisk ,Novo Nordisk ,Holst Lange ,Executive Vice President ,